U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 34

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:70303596
GRCh38:
Chr16:70269693
AARS1R296QDevelopmental and epileptic encephalopathy, 29Uncertain significance
(Apr 24, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr16:70310915
GRCh38:
Chr16:70277012
AARS1T96IDevelopmental and epileptic encephalopathy, 29Uncertain significance
(Apr 24, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr16:70310970
GRCh38:
Chr16:70277067
AARS1A78SDevelopmental and epileptic encephalopathy, 29Uncertain significance
(Jul 25, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr16:70316526
GRCh38:
Chr16:70282623
AARS1N47KDevelopmental and epileptic encephalopathy, 29Uncertain significance
(Jun 30, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr16:70310961
GRCh38:
Chr16:70277058
AARS1K81EDevelopmental and epileptic encephalopathy, 29Uncertain significance
(May 22, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr16:70311041
GRCh38:
Chr16:70277138
AARS1L54PDevelopmental and epileptic encephalopathy, 29Uncertain significance
(May 22, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr16:70292997
GRCh38:
Chr16:70259094
AARS1Charcot-Marie-Tooth disease type 2Likely benign
(Oct 17, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr16:70292978
GRCh38:
Chr16:70259075
AARS1R633fsDevelopmental and epileptic encephalopathy, 29Likely pathogenicno assertion criteria provided
9.
GRCh37:
Chr16:70316581
GRCh38:
Chr16:70282678
AARS1S29FDevelopmental and epileptic encephalopathy, 29Uncertain significanceno assertion criteria provided
10.
GRCh37:
Chr16:70292045-70292046
GRCh38:
Chr16:70258142-70258143
AARS1Y690fsDevelopmental and epileptic encephalopathy, 29Pathogenic
(Mar 2, 2022)
no assertion criteria provided
11.
GRCh37:
Chr16:70293089
GRCh38:
Chr16:70259186
AARS1P596SDevelopmental and epileptic encephalopathy, 29Uncertain significance
(Feb 3, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr16:70296346
GRCh38:
Chr16:70262443
AARS1C525YDevelopmental and epileptic encephalopathy, 29Likely pathogenic
(Jun 5, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr16:70305792-70305793
GRCh38:
Chr16:70271889-70271890
AARS1S188LDevelopmental and epileptic encephalopathy, 29Pathogenic
(Jun 5, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr16:70310906
GRCh38:
Chr16:70277003
AARS1E99GDevelopmental and epileptic encephalopathy, 29Pathogeniccriteria provided, single submitter
15.
GRCh37:
Chr16:70292906
GRCh38:
Chr16:70259003
AARS1N657DCharcot-Marie-Tooth disease type 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N,
Developmental and epileptic encephalopathy, 29, Leukoencephalopathy, hereditary diffuse, with spheroids 2
Uncertain significance
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr16:70294991
GRCh38:
Chr16:70261088
AARS1G581SDevelopmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2Conflicting interpretations of pathogenicity
(Dec 17, 2021)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr16:70316593
GRCh38:
Chr16:70282690
AARS1Y25CDevelopmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2, not provided
Uncertain significance
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr16:70292116
GRCh38:
Chr16:70258213
AARS1V666Anot provided, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2
Conflicting interpretations of pathogenicity
(Aug 23, 2023)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr16:70302257
GRCh38:
Chr16:70268354
AARS1R330*Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2Conflicting interpretations of pathogenicity
(Jun 10, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr16:70304137
GRCh38:
Chr16:70270234
AARS1T260ACharcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29Conflicting interpretations of pathogenicity
(Aug 13, 2021)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr16:70286658
GRCh38:
Chr16:70252755
AARS1F958SDevelopmental and epileptic encephalopathy, 29Likely pathogenic
(Apr 25, 2018)
no assertion criteria provided
22.
GRCh37:
Chr16:70303524
GRCh38:
Chr16:70269621
AARS1R320HCharcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive,
Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr16:70310943
GRCh38:
Chr16:70277040
AARS1D87Nnot provided, Charcot-Marie-Tooth disease type 2Uncertain significance
(Aug 5, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr16:70316697-70316698
GRCh38:
Chr16:70282794-70282795
AARS1not specified, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29,
Trichothiodystrophy 8, nonphotosensitive, Leukoencephalopathy, hereditary diffuse, with spheroids 2
Likely benign
(Oct 26, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr16:70287177
GRCh38:
Chr16:70253274
AARS1Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, not provided,
Charcot-Marie-Tooth disease axonal type 2N
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr16:70302201
GRCh38:
Chr16:70268298
AARS1Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease axonal type 2N,
Charcot-Marie-Tooth disease type 2, not specified, Charcot-Marie-Tooth disease axonal type 2N,
Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr16:70286793
GRCh38:
Chr16:70252890
AARS1G913DCharcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, not provided
Conflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr16:70289731
GRCh38:
Chr16:70255828
AARS1R729QInborn genetic diseases, Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29,
Charcot-Marie-Tooth disease axonal type 2N, not provided
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr16:70298949
GRCh38:
Chr16:70265046
AARS1not specified, not provided, Inborn genetic diseases,
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease axonal type 2N,
Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr16:70286631
GRCh38:
Chr16:70252728
AARS1K967MCharcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, not provided,
Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Developmental and epileptic encephalopathy, 29,
Trichothiodystrophy 8, nonphotosensitive
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr16:70304215
GRCh38:
Chr16:70270312
AARS1P234SInborn genetic diseases, Charcot-Marie-Tooth disease type 2, Leukoencephalopathy, hereditary diffuse, with spheroids 2,
Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29,
not provided, Charcot-Marie-Tooth disease axonal type 2N
Benign/Likely benign
(Sep 1, 2023)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr16:70295064
GRCh38:
Chr16:70261161
AARS1Inborn genetic diseases, not specified, Charcot-Marie-Tooth disease type 2,
not provided, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive,
Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease axonal type 2N
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr16:70289666
GRCh38:
Chr16:70255763
AARS1R751GInborn genetic diseases, Charcot-Marie-Tooth disease, not provided,
AARS-related disorders, Charcot-Marie-Tooth disease type 2
Conflicting interpretations of pathogenicity
(Nov 3, 2023)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr16:70310960
GRCh38:
Chr16:70277057
AARS1K81Tnot providedLikely pathogenic
(Jun 3, 2015)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination